V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001546 | 330006501 | 1.7 | 25.8 | Not known (9) | 2017-04-09 | 2017-04-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330005153 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001547 | 330000871 | null | 67.9 | Curative (C) | 2013-05-02 | 2013-05-14 | Cisplatin | N | N | 330005156 | CISPLATIN |
| 330001548 | 330000871 | 1.57 | 65.9 | Neo-adjuvant (N) | 2015-06-29 | 2015-07-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330005156 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001549 | 330000871 | 1.58 | 55.65 | Curative (C) | 2014-05-16 | 2014-05-19 | Trial Unspecified | 01 | N | 330005156 | TRIAL |
| 330001550 | 330000871 | null | 63 | null | 2015-03-24 | 2015-04-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330005156 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001551 | 330000872 | null | 71.6 | Curative (C) | 2017-07-10 | 2017-07-10 | SCART TRIAL | 2 | N | 330005162 | NOT MATCHED |
| 330001552 | 330000873 | 0 | 110 | Neo-adjuvant (N) | 2017-07-30 | 2017-07-31 | NB HRNBL-1 TVD | N | N | 330005164 | NOT MATCHED |
| 330001553 | 330006503 | null | 50.7 | Curative (C) | 2017-01-18 | 2017-01-30 | Trial Unspecified | Y | N | 330005168 | TRIAL |
| 330001554 | 330000874 | null | 64.2 | Neo-adjuvant (N) | null | 2014-11-17 | Trial Unspecified | Y | Y | 330005172 | TRIAL |
| 330001555 | 330000874 | 1.51 | 50 | Not known (9) | 2015-01-14 | 2015-01-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330005172 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001556 | 330000874 | null | 8.9 | Palliative (P) | 2014-03-24 | 2014-03-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330005172 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001557 | 330000874 | 1.6 | 47.49 | Neo-adjuvant (N) | 2015-12-08 | 2015-12-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005172 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001558 | 330000875 | 0 | null | Palliative (P) | 2013-10-08 | 2013-10-09 | Trial Unspecified | 1 | Y | 330005195 | TRIAL |
| 330001559 | 330000876 | 1.7 | 40.6 | Neo-adjuvant (N) | 2015-12-06 | 2015-12-28 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330005197 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001560 | 330000877 | 1.04 | 96 | Curative (C) | 2014-07-29 | 2014-07-29 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | 330005201 | NOT MATCHED |
| 330001561 | 330000878 | 0 | 68.2 | Curative (C) | 2015-11-25 | 2015-11-25 | NB HRNBL-1 COJEC Ind COURSE A | 2 | N | 330005202 | NOT MATCHED |
| 330001562 | 330000878 | 1.9 | 64.9 | Neo-adjuvant (N) | 2017-11-02 | 2017-11-02 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005202 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001563 | 330000879 | 1.7 | 15.4 | Not known (9) | 2017-11-19 | 2017-11-19 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330005204 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001564 | 330000879 | 1.74 | 92.6 | Curative (C) | 2016-10-21 | 2016-10-23 | NB HRNBL-1 COJEC Ind COURSE A | 2 | N | 330005204 | NOT MATCHED |
| 330001565 | 330009518 | null | null | Curative (C) | 2013-04-06 | 2013-04-09 | OST Euramos 1 Closed Trial - Ai | null | N | 330005221 | NOT MATCHED |
| 330001566 | 330009518 | 1.54 | null | Curative (C) | null | 2013-05-13 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005221 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001567 | 330000880 | 0 | 82.3 | Curative (C) | 2014-01-25 | 2014-01-28 | EW EuroEwing 2012 Arm B VDC | null | Y | 330005238 | TRIAL |
| 330001568 | 330000881 | 1.69 | 60 | Neo-adjuvant (N) | 2013-07-09 | 2013-07-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005241 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001569 | 330000882 | 1.6 | null | Adjuvant (A) | 2013-10-22 | 2013-11-12 | Cisplatin 7 day | N | N | 330005246 | CISPLATIN |
| 330001570 | 330000883 | 1.65 | 67.5 | Adjuvant (A) | 2017-06-19 | 2017-06-19 | Cisplatin 7 day | N | N | 330005247 | CISPLATIN |
| 330001572 | 330000885 | null | null | Curative (C) | null | 2017-12-18 | Cisplatin | null | N | 330005253 | CISPLATIN |
| 330001573 | 330000886 | 0 | 76 | Curative (C) | 2014-08-27 | 2015-09-25 | CNS GCT II Non Germin - Std PEI | Y | N | 330005255 | NOT MATCHED |
| 330001574 | 330000887 | 1.62 | 66.7 | Neo-adjuvant (N) | 2017-11-07 | 2017-11-28 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005262 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001575 | 330000888 | null | 65.4 | Palliative (P) | null | 2015-01-10 | EW EuroEwing 2012 Arm B VDC | 2 | N | 330005264 | TRIAL |
| 330001576 | 330000889 | 1.69 | 82.6 | Curative (C) | 2013-07-10 | 2013-07-10 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330005265 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001577 | 330000890 | 0 | 67.8 | Curative (C) | 2016-08-03 | 2016-08-12 | CNS GCT II Non Germin - Std PEI | N | N | 330005267 | NOT MATCHED |
| 330001581 | 330000892 | 0 | 65 | Curative (C) | 2013-09-01 | 2013-09-06 | WT SIOP 2002 01 post op Carbo, Etop | Y | N | 330005281 | NOT MATCHED |
| 330001582 | 330000893 | null | null | Neo-adjuvant (N) | 2016-08-23 | 2016-08-23 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330005285 | NOT MATCHED |
| 330001583 | 330000893 | 1.4 | 87 | Curative (C) | 2017-01-22 | 2017-01-22 | LCHIV SL-CT 6MP/MTX | N | N | 330005285 | NOT MATCHED |
| 330001584 | 330000894 | 1.69 | 22.5 | Curative (C) | 2015-08-24 | 2015-08-25 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330005288 | TRIAL |
| 330001585 | 330000895 | 1.74 | 63.95 | Curative (C) | 2015-10-18 | 2015-10-18 | STS Non-Rhabdo EpSSG 2005 IE | N | N | 330005293 | NOT MATCHED |
| 330001586 | 330000896 | 1.55 | null | Neo-adjuvant (N) | 2017-03-17 | 2017-03-17 | Trial Unspecified | Y | N | 330005294 | TRIAL |
| 330001587 | 330000897 | 1.61 | 13.8 | Neo-adjuvant (N) | 2016-06-10 | 2016-06-24 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330005297 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001588 | 330000897 | 1.8 | 91.2 | null | null | 2017-04-17 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005297 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001589 | 330000898 | null | 65.6 | Neo-adjuvant (N) | null | 2014-05-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005305 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001590 | 330000899 | 1.73 | 13.5 | Curative (C) | 2015-01-18 | 2015-02-06 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005311 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001591 | 330000899 | 1.73 | 46.3 | Curative (C) | null | 2014-08-25 | Cisplatin | N | N | 330005311 | CISPLATIN |
| 330001592 | 330000899 | 1.84 | 74 | Neo-adjuvant (N) | 2014-12-29 | 2014-12-31 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330005311 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001593 | 330000900 | 1.63 | 99.4 | Palliative (P) | null | 2017-11-06 | Trial Unspecified | 1 | null | 330005315 | TRIAL |
| 330001594 | 330000901 | 1.75 | 27.3 | Curative (C) | 2013-03-28 | 2013-05-06 | Cisplatin | N | Y | 330005318 | CISPLATIN |
| 330001595 | 330000902 | 1.62 | 57.1 | Curative (C) | 2016-11-11 | 2016-11-15 | Cisplatin 7 day | N | N | 330005323 | CISPLATIN |
| 330001596 | 330000903 | 1.81 | 70 | Curative (C) | 2014-02-15 | 2014-02-15 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 330005325 | NOT MATCHED |
| 330001597 | 330000903 | 1.8 | 70 | Adjuvant (A) | 2013-07-02 | 2013-08-01 | Cisplatin | 02 | Y | 330005325 | CISPLATIN |
| 330001598 | 330000904 | 1.74 | 6.9 | Palliative (P) | null | 2014-08-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330005334 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001599 | 330000905 | 1.6 | null | Neo-adjuvant (N) | 2014-04-20 | 2014-05-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330005341 | CISPLATIN + DOCETAXEL + FLUOROURACIL |